HMGB1 and acute kidney injury: I.p. administration of either HMGB1 inhibitor (glycyrrhizin, 30 mg/kg) or LDH-A inhibitor (oxamate, 750 mg/kg) was performed prior to the combined application of lactate and low-dose LPS to establish the AKI mouse model.